Evidence map›Paper›PMID 30094601›Full record

ArticleMolecular and cellular biochemistry2019

High-fat diet abolishes the cardioprotective effects of ischemic postconditioning in murine models despite increased thioredoxin-1 levels.

Tamara Mazo, Verónica D Annunzio, Tamara Zaobornyj, Virginia Perez, Anabella Gomez, Gabriela Berg, Magali Barchuk, Georgina Ossani, Manuela Martinefski, Valeria Tripodi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tamara MazoDepartment of Pathology, Faculty of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950, 2nd floor, Buenos Aires, Argentina.
Verónica D AnnunzioDepartment of Pathology, Faculty of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950, 2nd floor, Buenos Aires, Argentina.
Tamara ZaobornyjSchool of Pharmacy and Biochemistry, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), University of Buenos Aires, Buenos Aires, Argentina.
Virginia PerezDepartment of Pathology, Faculty of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950, 2nd floor, Buenos Aires, Argentina.
Anabella GomezDepartment of Pathology, Faculty of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950, 2nd floor, Buenos Aires, Argentina.
Gabriela BergLaboratory of Lipids and Atherosclerosis, Department of Clinical Biochemistry, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Magali BarchukLaboratory of Lipids and Atherosclerosis, Department of Clinical Biochemistry, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Georgina OssaniDepartment of Pathology, Faculty of Medicine, University of Buenos Aires, Experimental and Applied Pathology Center, Buenos Aires, Argentina.
Manuela MartinefskiDepartment of Pharmaceutics Technology, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Valeria TripodiDepartment of Pharmaceutics Technology, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Néstor LagoDepartment of Pathology, Faculty of Medicine, University of Buenos Aires, Experimental and Applied Pathology Center, Buenos Aires, Argentina.
Ricardo J GelpiDepartment of Pathology, Faculty of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950, 2nd floor, Buenos Aires, Argentina. rgelpi@fmed.uba.ar.
University of Buenos Aires · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

SCHOLAR IN RESIDENCE PROGRAMF15TW000373 · FIC · U.S. FOGARTY INTERNATIONAL CENTER · PI STOFFEL, WILHELM · 1995 to 1997
–
National Agency for Technological and Scientific Promotion, Argentina PICT 0373National Council of Scientific and Technological Research, Argentina PIP 0012Universidad de Buenos Aires 20020110100159
6 · The paper itself

Abstract

Ischemic postconditioning (PostC) reduces infarct size in healthy experimental models. However, if protective effects of PostC are abolished during early stages of atherosclerotic and if this is related with a disbalance in mitochondrial energetics and alterations in thioredoxin-1 (Trx1) is still unknown. The objectives were to generate a murine high-fat diet (HFD)-fed model that developed in a phenotype consistent with early stages of atherosclerosis to then evaluate whether HFD exposure increased oxidative stress and consequently abolished the cardioprotection conferred by PostC. We used C57/BL6 mice fed with control diet (CD) or HFD for 12 weeks. Isolated mice hearts were subjected to 30 min of ischemia and 120 min of reperfusion (I/R group). For PostC group, after ischemia, six cycles of reperfusion/ischemia were performed (10 s per cycle) at the onset of reperfusion. In CD group, the PostC reduced infarct size (CD-I/R: 52.14 ± 2.8 vs. CD-PostC: 36.58 ± 1.8, P < 0.05) and increased phosphorylation of GSK3β (CD-PostC: 2.341 ± 1.03 vs. CD-Baseline: 0.923 ± 0.41 AUOD, P < 0.05), and this cardioprotection was abolished in HFD-exposed mice. HFD increased hydrogen peroxide levels, produced a shift towards an oxidized intracellular environment (GSSG/GSH

Indexed as

Disease Models, AnimalIschemic PostconditioningAnimalsDiet, High-FatMaleMiceMice, Inbred C57BLMitochondriaMyocardial Reperfusion InjuryOxidation-ReductionThioredoxinsThioredoxinsHigh-fat dietIschemic postconditioningOxidative stressThioredoxin

Identifiers

PMID30094601
OpenAlexW2885324098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.